Updates
Here you’ll find the latest headlines from our project. Stay up to date on our latest news items.
Retrospective & Prospective Study – Update Work Package 1 (WP1)
First Webinar of 2022 by Bali Pulendran
Highlights and achievements – Update Work Package 2 (WP2)
VITAL Amendment
Qualitative Evidence Synthesis – Update Workpackage 4 (WP4)
Happy New Year!
Update WP1 & WP3
Young & Vital
Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
VITAL Webinar – Altered Naive T cell Metabolism with Ageing
World Pneumonia Day 2021
Dr. Jean-Pierre Michel on the Importance of VITAL
Young Investigators in Action
Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond
The Consortium Assembled
News from the VITAL consortium
Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom
Healthcare Workers’ Perceptions and Experiences of Communicating with People over 50 about Vaccination
VITAL Webinar – From Policy to Implementation: A Global Analysis of Country Approaches to Adult Vaccination
What Do Healthcare Professionals Need? – Update WP4
Developing, Constructing and Assessing – Update WP3
Research after Vaccinations – Update WP2
Publications and Inclusions – Update WP1
Presentation at IAGG-ER: A Brief Introduction and the Goals of VITAL
VITAL Presents Poster at ISPOR 2021
VITAL Webinar – Gut Microbiome and Respiratory Infections
European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
The Epidemiology Research Started – Update WP1
Follow-ups and Analyzing Data – Update WP2
Directions for Health Economic Research – Update WP3
New Results on Vaccination Communication – Update WP4
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
Brochure on Vaccination Communication
Health Economics of Vaccines: From Current Practice to Future Perspectives
Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach
Making Important Progress – Update WP3
Starting a New Study – Update WP1
Trial Progress During Challenging Times – Update WP2
VITAL Presents Poster at ISPOR 2020
